NASDAQ$BTTC

Black Titan Corp · Q4 2011 earnings

Q4 2011 earnings · · Investor relations

Headline financials

Total Revenue

$1.41M

Previous: $2.73M-48.2%
EPS (adj)

-$7.81

Previous: -$71.84+89.1%
Capital Expenditures

$178K

No prior period
Free Cash Flow

-$2.37M

No prior period
Net Income

-$2.9M

Previous: -$4.3M+32.6%
Operating Income

-$766K

Previous: -$3.98M+80.8%
Gross Profit

$1.41M

Previous: $2.73M-48.2%
Cash & Equivalents

$5.41M

No prior period
Total Assets

$10.2M

No prior period
Stock-Based Comp

$369K

No prior period

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$1.41M

Q4 2011-48.2%vs Q4 2010
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro